Nicholas Haft - 20 Dec 2021 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Director
Signature
/s/ Nicholas Haft
Issuer symbol
FNCH
Transactions as of
20 Dec 2021
Net transactions value
+$649,993
Form type
4
Filing time
22 Dec 2021, 17:21:38 UTC
Next filing
15 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FNCH Common Stock, $0.001 par value per share Purchase $649,993 +63,850 +1.6% $10.18 4,056,907 20 Dec 2021 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares are held indirectly by entities of which the reporting person is the manager. The reporting person has voluntarily reported the entire amount of such entities' interest. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any such securities.